These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9547136)

  • 1. Serotonin syndrome--clomipramine too soon after moclobemide?
    Gillman PK
    Int Clin Psychopharmacol; 1997 Nov; 12(6):339-42. PubMed ID: 9547136
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin syndrome caused by a clomipramine-moclobemide interaction.
    Dardennes RM; Even C; Ballon N; Bange F
    J Clin Psychiatry; 1998 Jul; 59(7):382-3. PubMed ID: 9714270
    [No Abstract]   [Full Text] [Related]  

  • 3. Serotonin syndrome with moclobemide-fluoxetine combination.
    Benazzi F
    Pharmacopsychiatry; 1996 Jul; 29(4):162. PubMed ID: 8858717
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonin syndrome in the elderly after antidepressive monotherapy.
    Fischer P
    J Clin Psychopharmacol; 1995 Dec; 15(6):440-2. PubMed ID: 8748434
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of serotonin syndrome with chlorpromazine.
    Gillman PK
    Med J Aust; 1996 Sep; 165(6):345-6. PubMed ID: 8862337
    [No Abstract]   [Full Text] [Related]  

  • 6. Serotonin syndrome caused by a moclobemide-clomipramine interaction.
    Spigset O; Mjörndal T; Lövheim O
    BMJ; 1993 Jan; 306(6872):248. PubMed ID: 8443525
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and adverse effects of moclobemide.
    Brodribb TR; Downey M; Gilbar PJ
    Lancet; 1994 Feb; 343(8895):475. PubMed ID: 7905962
    [No Abstract]   [Full Text] [Related]  

  • 8. Serotonin syndrome in combined moclobemide and venlafaxine ingestion.
    Roxanas MG; Machado JF
    Med J Aust; 1998 May; 168(10):523-4. PubMed ID: 9631680
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and tolerability of combined treatment with moclobemide and SSRIs: a systematic study of 50 patients.
    Hawley CJ; Quick SJ; Ratnam S; Pattinson HA; McPhee S
    Int Clin Psychopharmacol; 1996 Sep; 11(3):187-91. PubMed ID: 8923097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Depressive stupor--malignant neuroleptic syndrome--serotonin syndrome. A case contribution to a difficult differential diagnosis].
    König F; Löble M; Wolfersdorf M
    Nervenarzt; 1996 May; 67(5):407-12. PubMed ID: 9005353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal serotonin syndrome caused by moclobemide-clomipramine overdose.
    Ferrer-Dufol A; Perez-Aradros C; Murillo EC; Marques-Alamo JM
    J Toxicol Clin Toxicol; 1998; 36(1-2):31-2. PubMed ID: 9541038
    [No Abstract]   [Full Text] [Related]  

  • 12. Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial.
    Larsen JK; Holm P; Mikkelsen PL
    Acta Psychiatr Scand; 1984 Sep; 70(3):254-60. PubMed ID: 6388247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
    Dierick M; Cattiez P; Franck G; Burton P; Defleur J; Hermans W; Roelandts A; Wolfrum C; Berger M; Hellstern K
    Acta Psychiatr Scand Suppl; 1990; 360():50-1. PubMed ID: 2248071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder.
    Krüger MB; Dahl AA
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S19-24. PubMed ID: 10361962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin syndrome due to an overdose of moclobemide and clomipramine. A potentially life-threatening association.
    François B; Marquet P; Desachy A; Roustan J; Lachatre G; Gastinne H
    Intensive Care Med; 1997 Jan; 23(1):122-4. PubMed ID: 9037653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moclobemide (Ro 11-1163) safety in depressed patients.
    Moll E; Hetzel W
    Acta Psychiatr Scand Suppl; 1990; 360():69-70. PubMed ID: 2248078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of the toxic serotonin syndrome with chlorpromazine.
    Graham PM
    Med J Aust; 1997 Feb; 166(3):166-7. PubMed ID: 9059446
    [No Abstract]   [Full Text] [Related]  

  • 18. A risk-benefit assessment of moclobemide in the treatment of depressive disorders.
    Norman TR; Burrows GD
    Drug Saf; 1995 Jan; 12(1):46-54. PubMed ID: 7741983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1993 Jun; 28(2):105-16. PubMed ID: 8354766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIMA--a new concept in the treatment of depression with moclobemide.
    Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.